/ Unknown statusPhase 4IIT A 2-year, Open-label, Randomized Study to Evaluate the Efficacy of Rosuvastatin Dosing Adjustment by LDL-C Level Compared to That of 5mg Maintenance Dose in Chinese Patients With Carotid Atherosclerotic Plaques
This is a 2-year, open-label, randomized study to evaluate the efficacy of Rosuvastatin dosing adjustment by LDL-C level compared to that of 5mg maintenance dose in chinese patients with Carotid Atherosclerosis.
100 Clinical Results associated with Beijing Kelin Shengtai Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Kelin Shengtai Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Beijing Kelin Shengtai Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Kelin Shengtai Pharmaceutical Technology Development Co., Ltd.